Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 7/20 | 0.35 |
| ▸ | TAS1R1 | Q7RTX1 | 7/20 | 0.35 |
| ▸ | TAS1R2 | Q8TE23 | 7/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12859001 | 0.94 | TAS1R3 (0.33) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL18745493 | 0.92 | TAS1R3 (0.32) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL12912877 | 0.91 | TAS1R3 (0.34) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL24250416 | 0.88 | TAS1R3 (0.33) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL12946115 | 0.88 | TAS1R3 (0.31) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL13105370 | 0.87 | TAS1R3 (0.31) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL23105014 | 0.87 | TAS1R3 (0.31) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL12180002 | 0.87 | — | — | |
| SCHEMBL18745544 | 0.85 | — | — | |
| SCHEMBL24282821 | 0.85 | TAS1R3 (0.32) | TAS1R3TAS1R1TAS1R2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4306538-A2 | PEPTIDE OLIGONUCLEOTIDE CONJUGATES | Sarepta Therapeutics, Inc. (US) | 2024-01-17 | — | — | EP | disclosed |
| US-20230337677-A1 | ARYL AND PYRIDYL AMIDE PESTICIDES AND COMPOSITIONS THEREOF | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED | 2023-10-26 | — | — | US | disclosed |
| US-20230293701-A1 | LIGAND COMPOUNDS, CONJUGATES, AND APPLICATIONS THEREOF | ARGORNA PHARMACEUTICALS CO., LTD. (CN) | 2023-09-21 | — | — | US | disclosed |
| US-11760775-B2 | Steroids and protein-conjugates thereof | REGENERON PHARMACEUTICALS, INC. | 2023-09-19 | — | — | US | disclosed |
| US-20230265055-A1 | STAT INIHIBITORY COMPOUNDS AND COMPOSITIONS | OXFORD FINANCE LLC | 2023-08-24 | — | — | US | disclosed |
| WO-2023118576-A1 | DHODH INHIBITORS CONTAINING A CARBOXYLIC ACID BIOISOSTERE | IMMUNIC AG (DE) | 2023-06-29 | — | — | WO | disclosed |
| US-20230174506-A1 | (DI)AMINATION OF ACTIVATED ALLENE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS FOR SYNTHESIS OF THE SAME | PURDUE RESEARCH FOUNDATION | 2023-06-08 | — | — | US | disclosed |
| US-20230150946-A1 | HETEROCYCLE CONTAINING STAT INHIBITORS AND COMPOSITIONS | OXFORD FINANCE LLC | 2023-05-18 | — | — | US | disclosed |
| US-20230137943-A1 | PHOTOPROXIMITY PROFILING OF PROTEIN-PROTEIN INTERACTIONS IN CELLS | THE UNIVERSITY OF CHICAGO | 2023-05-04 | — | — | US | disclosed |
| US-11612604-B2 | Methods of treating cancer with PLK4 inhibitors | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD (CH) | 2023-03-28 | — | — | US | disclosed |
| US-20110045100-A1 | Antimalarial Quinolines and Methods of Use Thereof | GEORGETOWN UNIVERSITY (US) | 2011-02-24 | — | — | US | disclosed |
| US-20100317643-A1 | JANUS KINASE INHIBITOR COMPOUNDS AND METHODS | GENENTECH, INC. (US) | 2010-12-16 | — | — | US | disclosed |
| US-20100284953-A1 | HAIR CARE COMPOSITIONS AND METHODS OF TREATING HAIR USING SAME | LIVING PROOF, INC. (US) | 2010-11-11 | — | — | US | disclosed |
| US-20100284939-A1 | HAIR CARE COMPOSITIONS AND METHODS OF TREATING HAIR USING SAME | LIVING PROOF, INC. (US) | 2010-11-11 | — | — | US | disclosed |
| US-7785575-B2 | controlling frizz in scalp hair by applying a mixture of a nonpolymeric fluorinated ester such as hexafluoroisopropyl 2-fluoroacrylate, water, emulsifiers and flow control agents | LIVING PROOF, INC. (US) | 2010-08-31 | — | — | US | disclosed |
| US-7763240-B2 | Hair care compositions and methods of treating hair using same | LIVING PROOF, INC. (US) | 2010-07-27 | — | — | US | disclosed |
| US-20100035070-A1 | FUSER MEMBER COATING HAVING POLYSILSESQUIOXANE OUTER LAYER | XEROX CORPORATION (US) | 2010-02-11 | — | — | US | disclosed |
| US-20090226382-A1 | HAIR CARE COMPOSITIONS AND METHODS OF TREATING HAIR USING SAME | LIVING PROOF, INC. (US) | 2009-09-10 | — | — | US | disclosed |
| US-20090191141-A1 | HAIR CARE COMPOSITIONS AND METHODS OF TREATING HAIR USING SAME | LIVING PROOF, INC. (US) | 2009-07-30 | — | — | US | disclosed |
| US-20090104136-A1 | HAIR CARE COMPOSITIONS AND METHODS OF TREATING HAIR USING SAME | LIVING PROOF, INC. | 2009-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (15 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150946-A1 | HETEROCYCLE CONTAINING STAT INHIBITORS AND COMPOSITIONS | STAT5A, STAT5B, STAT3 | TAS1R3 3958/4885TAS1R1 3882/4885TAS1R2 3968/4885 |
| US-20100284939-A1 | HAIR CARE COMPOSITIONS AND METHODS OF TREATING HAIR USING SAME | TET1, TET2, TET3 | TAS1R3 998/4885TAS1R1 1349/4885TAS1R2 1592/4885 |
| US-20090226382-A1 | HAIR CARE COMPOSITIONS AND METHODS OF TREATING HAIR USING SAME | TET1, TET2, TET3 | TAS1R3 998/4885TAS1R1 1349/4885TAS1R2 1592/4885 |
| US-20230174506-A1 | (DI)AMINATION OF ACTIVATED ALLENE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS FOR SYNTHESIS OF THE SAME | NAAA, PAM, AANAT | TAS1R3 4567/4885TAS1R1 4554/4885TAS1R2 4543/4885 |
| US-11612604-B2 | Methods of treating cancer with PLK4 inhibitors | PLK4, PLK2, PLK3 | TAS1R3 4831/4885TAS1R1 4853/4885TAS1R2 4849/4885 |
| US-20100317643-A1 | JANUS KINASE INHIBITOR COMPOUNDS AND METHODS | JAK2, JAK1, JAK3 | TAS1R3 1766/4885TAS1R1 1466/4885TAS1R2 1886/4885 |
| US-20100284953-A1 | HAIR CARE COMPOSITIONS AND METHODS OF TREATING HAIR USING SAME | TET1, TET2, TET3 | TAS1R3 998/4885TAS1R1 1349/4885TAS1R2 1592/4885 |
| US-20110045100-A1 | Antimalarial Quinolines and Methods of Use Thereof | NQO2, QTRT1, QTRT2 | TAS1R3 4519/4885TAS1R1 4721/4885TAS1R2 4636/4885 |
| US-20090104136-A1 | HAIR CARE COMPOSITIONS AND METHODS OF TREATING HAIR USING SAME | TET1, TET2, TET3 | TAS1R3 998/4885TAS1R1 1349/4885TAS1R2 1592/4885 |
| US-20230137943-A1 | PHOTOPROXIMITY PROFILING OF PROTEIN-PROTEIN INTERACTIONS IN CELLS | PPIA, S100A4, S100A6 | TAS1R3 4658/4885TAS1R1 4785/4885TAS1R2 4783/4885 |
| US-20090191141-A1 | HAIR CARE COMPOSITIONS AND METHODS OF TREATING HAIR USING SAME | TET1, TET2, TET3 | TAS1R3 998/4885TAS1R1 1349/4885TAS1R2 1592/4885 |
| US-20230337677-A1 | ARYL AND PYRIDYL AMIDE PESTICIDES AND COMPOSITIONS THEREOF | DDT, ACHE, AHR | TAS1R3 1182/4885TAS1R1 2105/4885TAS1R2 1899/4885 |
| US-20230293701-A1 | LIGAND COMPOUNDS, CONJUGATES, AND APPLICATIONS THEREOF | ASGR1, HAVCR2, SLC10A1 | TAS1R3 2609/4885TAS1R1 2512/4885TAS1R2 2407/4885 |
| US-20230265055-A1 | STAT INIHIBITORY COMPOUNDS AND COMPOSITIONS | STAT5B, STAT5A, STAT3 | TAS1R3 4187/4885TAS1R1 4055/4885TAS1R2 4043/4885 |
| US-11760775-B2 | Steroids and protein-conjugates thereof | SERPINA6, NR3C1, NR3C2 | TAS1R3 4800/4885TAS1R1 4781/4885TAS1R2 4803/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.